Showing 1391-1400 of 6664 results for "".
Noah Worcester 2024: Dr. Webster on Isotretinoin
https://practicaldermatology.com/conferences/noah-worcester-2024/noah-worcester-2024-dr-webster-isotretinoin/24581/Guy Webster, MD, PhD, FAAD, summarizes his lecture on new developments in isotretinoin at the 2024 Noah Worcester Dermatological Society meeting.James Del Rosso, DO: Thoughts on the FDA Citizen's Petition for Acne Products with Benzoyl Peroxide (BPO)
https://practicaldermatology.com/topics/acne-rosacea/james-del-rosso-do-thoughts-fda-citizens-petition-acne-products-benzoyl-peroxide-bpo/24173/James Q. Del Rosso, DO, a dermatologist and president of The American Acne and Rosacea Society (AARS), weighs in on a recent report from Valisure which finds that benzene can form at elevated levels in products for acne that contain benzoyl peroxide (BPO). The interview was conducted by Neal Bhatia,How Air Pollution Affects the Skin
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/how-air-pollution-affects-the-skin/20259/Mark Birch-Machin, PhD, a professor of molecular dermatology at New Castle University, talks about the effects that air pollution can have on skin. Dr. Birch-Machin also talks about a recent study his team published in FASEB BioAdvances looking at the effects of air pollution on human skin equivalenSocial media marketing trends for 2022 and beyond
https://practicaldermatology.com/topics/practice-management/social-media-marketing-trends-for-2022-and-beyond/20095/Social media is no longer the new frontier in digital marketing. It is a vital part of daily life for much of your audience. That means it is an indispensable part of a good marketing strategy for your dermatology practice. This short video from Ekwa Marketing (www.ekwa.com) covers the latest trendsWinning Combinations in Scar Revision
https://practicaldermatology.com/conferences/asds-2021/winning-combinations-in-scar-revision/20028/Sherrif F. Ibrahim, MD, PhD says a combination approach is often best when it comes to laser scar revision. He discusses the devices he uses to improve the color and texture of scars to meet his patients' needs.Initiating Biologics
https://practicaldermatology.com/topics/psoriasis/initiating-biologics/19986/Kara S. Gooding, MMS, PA-C offers an overview of a panel discussion about initiating treatment with biologics. The panel shared real-world applications, plus tips on lab monitoring, managing side effects, and choosing the right biologic.An Exciting Year in Dermatology
https://practicaldermatology.com/topics/psoriasis/an-exciting-year-in-dermatology/19929/From new topicals to novel systemic agents, several treatments may be coming to the market in the next two years, while existing therapies may see label expansions. Bruce Strober, MD, PhD offers a look at new MOAs and the evidence for their use.DermWireTV: AAD Virtual Data Highlights, Cynosure Consumer Data
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-aad-virtual-data-highlights-cynosure-consumer-data/19818/The American Academy of Dermatology 2020 VMX Virtual Conference shines a light on fresh data from UCB, Leo Pharma, Lilly and Dermira, and Soliton. Cassiopea reports long-term data for Clascoterone. Zilxi from Menlo and Foamix approved for rosacea. Cynosure reports positive cosmetic consumer outlookCOVID-19 Impact: Virtual Care for Young Patients
https://practicaldermatology.com/topics/practice-management/covid-19-impact-virtual-care-for-young-patients/19765/With most dermatology practices closing their doors during the COVID-19 pandemic, telemedicine is emerging as an effective option for patient care. Peter Lio, MD offers tips for overcoming technology difficulties and enhancing communication during teleconsults. He also offers insights into how he isPigmentation Disorders
https://practicaldermatology.com/topics/pigmentary-disorders/pigmentation-disorders/19730/Sunscreen may be the first, second, and third thing recommended for patients with pigmentation disorders, but what comes next? Joel Cohen, MD interviews Amit Pandya, MD to learn about treatment options and developments in the pipeline.